Inhibitory effects of tranilast on the proliferation and functions of human pterygium-derived fibroblasts

Cornea

Volumn 19, Issue 3, 2000, Pages 364-368

  Isaji, Masayuki ^a   Kikuchi, Shinji ^a   Miyata, Hiroshi ^a   Ajisawa, Yukiyoshi ^a   Araki Inazawa, Kaori ^b   Tsukamoto, Yuji ^b   Amano, Yoshinari ^b  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

^b NONE

Author keywords

Chemotaxis; Collagen gel contraction; Collagen synthesis; Fibroblasts; Proliferation; Pterygium; Tranilast

Indexed keywords

ANTIALLERGIC AGENT; TRANILAST;

ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ANGIOGENESIS; ARTICLE; CELL GROWTH; CHEMOTAXIS; COLLAGEN SYNTHESIS; DRUG MECHANISM; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PTERYGIUM;

ACTINS; ANTHRANILIC ACIDS; ANTI-ALLERGIC AGENTS; CELL DIVISION; CELLS, CULTURED; CHEMOTAXIS; COLLAGEN; FIBROBLASTS; HUMANS; IMMUNOENZYME TECHNIQUES; PTERYGIUM;

EID: 0034028237     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200005000-00021     Document Type: Article

References (21)

1. Azuma H, Banno K, Yoshimura T. Pharmacological properties of N-(3′,4′-dimethoxycinnamoyl)anthranilic acid (N-5′), a new anti-atopic agent. Br J Pharmacol 1976;58:483-8.
2. Koda A, Nagai H, Watanabe S, Yanagihara Y, Sakamoto K. Inhibition of hypersensitivity reactions by a new drug, N-(3′,4′-dimethoxycinnamoyl)anthranilic acid (N-5′). J Allergy Clin Immunol 1976;57: 396-407.
3. Isaji M, Miyata H, Ajisawa Y. Tranilast: a new application in the cardiovascular field as an antiproliferative drug. Cardiovasc Drug Rev 1998;16:288-99.
4. Isaji M, Nakajoh M, Naito J. Selective inhibition of collagen accumulation by W-(3,4-dimethoxycinnamoyl)anthranilic acid (N-5′) in granulation tissue. Biochem Pharmacol 1987;36:469-74.
5. Isaji M, Aruga N. Naito J, Miyata H. Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes and functions of fibroblasts in vitro. Life Sci 1994;55:PL287-92.
6. Yanagi T, Watanabe M, Fukuda S, Tsuji Y. Suppressive effects of tranilast (TN) on human mononuclear cells. Jpn J Inflammation 1987; 7:169-73.
7. Suzawa H, Kikuchi S, Arai N, Koda A. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 1992;60:91-6.
8. Tanaka K, Honda M, Kuramochi T, Morioka S. Prominent inhibitory effects of tranilast on migration and proliferation of collagen synthesis by vascular smooth muscle cells. Atherosclerosis 1994;107:179-85.
9. Fukuyama J, Ichikawa K, Miyazawa K, Hamano S, Shibata N, Ujiie A. Tranilast suppresses intimai hyperplasia in the balloon injury model and cuff treatment model in rabbits. Jpn J Pharmacol 1996;70:321-7.
10. Isaji M, Miyata H, Ajisawa Y, Takehana Y, Yoshimura N. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br J Pharmacol 1997;122:1061-6.
11. Isaji M, Miyata H, Ajisawa Y, Yoshimura N. Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats. Life Sci 1998;63:PL71-4.
12. Isaji M, Miyata H, Ajisawa Y, Yoshimura N. Inhibitory effects of tranilast on proliferative reactions, angiogenesis, and contraction of fibrotic tissue [Abstract]. Invest Ophthalmol Vis Sci 1997;38(suppl 2):S753.
13. Hill JC, Maske R. Pathogenesis of pterygium. Eye 1989;3:218-26.
14. Pinkerton OD, Hokama Y, Shigematsu LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol 1984;98:225-8.
15. Butrus SI, Ashraf MF, Laby DM, Rabinowitz AI, Tabbara SO, Hidayat AA. Increased numbers of mast cells in pterygia. Am J Ophthalmol 1995;119:236-7.
16. Peterkofsky B, Diegelmann R. Use of a mixture of proteinase-free collagenase for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 1971;10:988-93.
17. Dushku N, Reid TW. P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res 1997;16: 1179-92.
18. Okamoto S. Effect of tranilast on corneal haze after photorefractive keratectomy. Atarashii Gannka (J Eye) 1997;14:239-43.
19. Cardillo JA, Alves MR, Ambrosio LE, Poterio MB, Jose NK. Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Ophthalmology 1995; 102:1949-52.
20. Yuasa T, Shimizu Y, Kogure F, Mikuni I, Saiga T, Ogawa N. Clinical evaluation of tranilast ophthalmic solution in allergic conjunctivitis and vernal conjunctivitis by a multi-center double-blind comparative study: double-blind comparative study with placebo. J Clin Ther Med 1993;9:53-67.
21. Chen J-K, Tsai RJ-F, Lin S-S. Fibroblasts isolated from human pterygium exhibit transformed cell characteristics. In Vitro Cell Dev Biol 1993;30A:243-8.